SCA Pharmaceuticals, LLC
$806.08 7 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Shorla Oncology Inc.
Shorla Oncology Inc. reported $797.92 across General Payments, Research, and Ownership to 31 physicians and teaching hospitals across 31 transactions.
- $797.92 Below-median payer
- All-tracks total
- 31 Below-median volume
- Transactions
- 31 Below-median reach
- Recipients
- #1856
- of 1,925 companies
Shorla Oncology Inc. reported $797.92 across all CMS Open Payments tracks (General + Research + Ownership) to 31 physicians and teaching hospitals in Program Year 2024 - ranking #1856 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $797.92, averaging $25.74 per recipient.
Shorla Oncology Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
10/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer shorla-oncology-inc Shorla Oncology Inc.
$797.92 · #1856/1,925 · 0.0% industry · PY2024
- TOT $797.92
- RANK #1856
- SHARE 0.0%
- TXN 31
- RCP 31
- CAT 1
- GEN $797.92
- TOP1 8.0%
- PY 2024
Volume peers
Nearest volume peer: SCA Pharmaceuticals, LLC ($806.08)
Shorla Oncology Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Shorla Oncology Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Shorla Oncology Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
Of the 1 general-payment categories charted below, "Food and Beverage" is the largest at $797.92 across 31 transactions, 100.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Shorla Oncology Inc. made 1 types of general payments. "Food and Beverage" is the largest category at $797.92, 100.0% of General Payments.
How Shorla Oncology Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $797.92 | 31 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $227.49 (28.5%) of $797.92 in this company's General Payments records across 29 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Shorla Oncology Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Neha a Pansuria
$64.17 across 2 reported transactions
- 2
Barbara J Phelps
$45.43 across 1 reported transactions
- 3
Dedri Markita Ivory
$45.43 across 1 reported transactions
- 4
Lisa Kaye Proffitt
$38.37 across 1 reported transactions
- 5
Jason Su
$34.09 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Shorla Oncology Inc. ranks #1856 of 1,925 by total payments (bottom 4% by spend) but is notably more concentrated than that alone would suggest -- #1,373 of 1,838 by HHI (bottom 25% least concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Provepharm Inc. : $41.4K total payments, HHI 411
- TriSalus Life Sciences, Inc. : $443.3K total payments, HHI 411
- Tarsus Pharmaceuticals, Inc. : $5.3M total payments, HHI 409
- Roche Diagnostics Corporation : $552.8K total payments, HHI 407
- PROCEPT BioRobotics Corporation : $1.7M total payments, HHI 405
- Cerapedics Inc. : $796.4K total payments, HHI 405
- Shorla Oncology Inc. (this company) : $797.92 total payments, HHI 404
- Providence Medical Technology, Inc. : $467.9K total payments, HHI 404
- icotec Medical Inc. : $393.7K total payments, HHI 403
- Shionogi Inc : $1.4M total payments, HHI 403
- ALK-Abello, Inc : $339.4K total payments, HHI 403
- Verity Pharmaceuticals Inc. : $293.4K total payments, HHI 398
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Shorla Oncology Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Shorla Oncology Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Shorla Oncology Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Precision Medical Products Inc.
$832.29 17 recipients
Compare payment profiles
Nuo Therapeutics
$833.09 13 recipients
Compare payment profiles
McKesson Medical-Surgical Minnesota Supply, Inc
$837.57 25 recipients
Compare payment profiles
Omnia S.r.l
$752.44 4 recipients
Compare payment profiles
LockedBrands
$852.39 13 recipients
Compare payment profiles
Put this to use
Shorla Oncology Inc. ranks #1856 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Shorla Oncology Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.